Motif Bio
 | |
| | |
| Motif Bio PLC | |
|---|---|
| Type | Public |
| Industry | Biopharmaceuticals |
| Founded | 2014 |
| Headquarters | London, United Kingdom |
| Key people | Graham George Lumsden (CEO), David B. Huang (Chief Medical Officer), Robert Joseph Bertoldi [1] |
| Number of employees | 4 [2] |
We are a clinical stage biopharmaceutical company engaged in the research and development of novel antibiotics designed to be effective against serious and life-threatening infections in hospitalized patients caused by multi-drug resistant bacteria. [3] Its lead product candidate is Iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus and multi-drug resistant streptococcus pneumoniae. [4]
Contents
[hide]Products[edit | edit source]
Iclaprim is a dihydrofolate reductase (DHFR) inhibitor originally discovered by F. Hoffman-La Roche Ltd. Iclaprim was licensed to and developed by Arpida AG.
Iclaprim is a potential novel antibiotic, designed to be effective against bacteria that have developed resistance to other antibiotics, including trimethoprim. Iclaprim exhibits potent activity against Gram-positive clinical isolates of many genera of staphylococci, including methicillin sensitive staphylococci (MSSA) and methicillin resistant staphylococci (MRSA).
[5]
Controversies[edit | edit source]
Top 5 Recent Tweets[edit | edit source]
| Date | Author | Comment |
|---|---|---|
| April 09, 2023 | WmMorrisSocUK | Happy Easter! 🐤 In celebration of Easter we are sharing this unique pencil and watercolour design attributed to Joh… https://t.co/y0yy7AuCGg |
Top 5 Recent News Headlines[edit | edit source]
Top 5 Lifetime Tweets[edit | edit source]
Top 5 Lifetime News Headlines[edit | edit source]
- Jump up ↑ https://www.motifbio.com/about/management-team/
- Jump up ↑ http://www.nasdaq.com/markets/ipos/company/motif-bio-plc-998919-81297
- Jump up ↑ http://www.nasdaq.com/markets/ipos/company/motif-bio-plc-998919-81297#ixzz4QjOzZx00
- Jump up ↑ http://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=283471296
- Jump up ↑ https://www.motifbio.com/iclaprim/
